Light Mode
Dark Mode
System Mode
Trump’s FDA nominee faces intense scrutiny as summer foodborne outbreaks prompt bipartisan questions on safety oversight and regulatory readiness.
The White House has nominated Heidi Overton to lead the US Food and Drug Administration (FDA), a selection that comes after a summer marked by multiple foodborne illness outbreaks that sickened thousands, officials said. The nomination must be confirmed by the Senate; no hearing date has been set.
Public health data show the United States recorded over 17,000 confirmed cyclospora cases this summer linked to lettuce from Taylor Farms, a sharp rise from 1,180 cases the previous summer. Authorities also reported outbreaks of E. coli and salmonella tied to alfalfa sprouts, eggs, jalapenos, frozen blueberries and other products, and several recalls followed.
Former and current FDA officials and food safety advocates quoted in the source material said agency morale is low and that staffing reductions have hampered outbreak investigations and communication. The Health and Human Services department responded that the administration mounted a robust response to each outbreak and that no FDA investigators were affected by recent staffing changes.
The source material states that the FDA has been without a commissioner for roughly 3.5 months after Marty Makary resigned and that several senior leaders left the agency. It also reports that Health Secretary Robert F Kennedy reduced FDA staffing by about 20% the previous year and that these departures and cuts coincided with slower responses to this summer’s outbreaks, according to public health experts and advocates cited in the text.
The nomination of Heidi Overton is contextualized by her background as a former general surgery resident and as chief policy officer at the America First Policy Institute. The White House praised Overton and urged swift Senate confirmation, while some senators have expressed concerns related to her support for administration orders on vaccine scheduling, as recorded in the source material.